Drug
Teduglutide clinical trials
Also written Gattex, TAK-633, Revestive and ALX-0600.
- studies test it
- 35
- open now
- 1
- in phase 3
- 20
- first study started
- 2003
Keep track of what changes. Save the teduglutide studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Combined with it in one product
Studies by the year they started
35 studies that test it; most in 2018 (5)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 4 |
| 2018 | 5 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 2 |
| 2024 | 1 |
| 2025 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 6
- Phase 2
- 8
- Phase 3
- 20
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 24 · Other 11
Shire (19) · Takeda (3) · University Health Network, Toronto (3) · Nycomed (2) · Assistance Publique - Hôpitaux de Paris (1) · University of Freiburg (1) · Massachusetts General Hospital (1) · Daniel Dante Yeh (1)
Often tested with
Tested in the same studies.
Acetylglucosamine (1) · Budesonide (1) · Omega-N-Methylarginine (1)
Studies
Open first, then newest update. How each study uses teduglutide is read from its arms, and is right about nine times in ten.
Testing it · 35
- TED_ORG: Study on Short Bowel SyndromeRecruitingNot applicableMeyer Children's Hospital IRCCSNCT07400783Written as Teduglutide (ALX-0600)
- A Study of Teduglutide in Chinese Adults With Short Bowel SyndromeActive, not recruitingPhase 3TakedaNCT06973304Written as Teduglutide
- Characterization of the Long-term Safety, Efficacy, and Pharmacodynamics Revestive® in the Management of Short Bowel Syndrome Pediatric PatientsCompletedPhase 4Assistance Publique - Hôpitaux de ParisNCT03562130Written as Teduglutide
- Long-term Study of Teduglutide in Pediatric Subjects With Short Bowel Syndrome Who Completed the TED-C13-003 StudyCompletedPhase 3ShireNCT02949362Written as Teduglutide
- A Study of Teduglutide in Japanese Children With Short Bowel Syndrome Aged 4 Months or OlderCompletedPhase 3TakedaNCT05027308Written as Teduglutide
- Treatment of Patients With Teduglutide (GLP-2) for GVHD and Analysis of Paneth Cells of GVHD PatientsCompletedEarly Phase 1University of FreiburgNCT04290429Written as Teduglutide
- A Study of the Gut Barrier and Blood Vessel Inflammation in Individuals With and Without HIVCompletedPhase 2Massachusetts General HospitalNCT02431325Written as Teduglutide
- An Extension Study of Teduglutide in Japanese Participants With Short Bowel Syndrome Who Completed 24 Weeks of Treatment in SHP633-306 or TED-C14-004CompletedPhase 3TakedaNCT03596164Written as Teduglutide
- Pilot Study to Investigate the Effect of Teduglutide on Temporary Ileostomy Function and ComplicationsWithdrawnPhase 3Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)NCT03953170Written as Teduglutide
- A Study to Evaluate the Bioavailability of Teduglutide Administered Subcutaneously by Syringe Injection Versus Pen Injector in Healthy Adult ParticipantsCompletedPhase 1ShireNCT04465396Written as Teduglutide
- Plasma Lipoprotein Response to Glucagon-like Peptide-2CompletedPhase 2/3University Health Network, TorontoNCT03422666Written as Teduglutide
- Glucagon-like Peptide-2 Mediated Secretion of Stored Enteral LipidsCompletedPhase 2/3University Health Network, TorontoNCT03442972Written as Teduglutide
- A Study in Japanese Children With Short Bowel Syndrome Who Completed SHP633-302CompletedPhase 3ShireNCT03268811Written as Teduglutide
- Study in Japanese Pediatric Subjects With Short Bowel Syndrome (SBS) Who Are Dependent on Parenteral SupportCompletedPhase 3ShireNCT02980666Written as Teduglutide
- Teduglutide for Enterocutaneous Fistula (ECF)CompletedPhase 2Daniel Dante YehNCT02889393Written as Teduglutide
- Therapeutic Approaches to Malnutrition EnteropathyCompletedPhase 2Queen Mary University of LondonNCT03716115Written as Teduglutide
- Open-Label Study of Teduglutide for Subjects With PN-Dependent Short Bowel Syndrome (SBS)CompletedPhase 3ShireNCT00930644Written as teduglutide
- A One-Year, Open-Label Study With Teduglutide for Subjects Who Completed Study CL0600-021CompletedPhase 3ShireNCT01560403Written as Teduglutide
- A Pharmacokinetic, Safety, and Pharmacodynamic Study of Teduglutide in Pediatric Subjects With Short Bowel SyndromeCompletedPhase 3ShireNCT01952080Written as teduglutide
- Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel SyndromeCompletedPhase 3ShireNCT00081458Written as Teduglutide 0.05 mg/kg/d
Codes
What other systems call teduglutide · ClinicalTrials.gg INT004730
- MeSH (NLM) C494910teduglutideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7M19191IKGTEDUGLUTIDEConfirmed FDA, NLM, Wikidata
- RxNorm 1364468Confirmed FDA, Wikidata
- Wikidata Q7694156teduglutideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C66582TeduglutideConfirmed FDA, Wikidata
- DrugBank DB08900One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C494910 | teduglutide | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7M19191IKG | TEDUGLUTIDE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 1364468 | — | Confirmed FDA, Wikidata |
| Wikidata | Q7694156 | teduglutide | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C66582 | Teduglutide | Confirmed FDA, Wikidata |
| DrugBank | DB08900 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.